Improved cognitive-cerebral function in older adults with chromium supplementation

Nutritional Neuroscience

Volumn 13, Issue 3, 2010, Pages 116-122

  Krikorian, Robert ^a   Eliassen, James C ^a   Boespflug, Erin L ^a   Nash, Tiffany A ^a   Shidler, Marcelle D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimers disease; Brain activation; Chromium; Insulin resistance; Memory; Mild cognitive impairment

Indexed keywords

CHROMIUM PICOLINATE; PLACEBO;

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEARNING DISORDER; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MENTAL TASK; NERVE DEGENERATION; PARIETAL LOBE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECALL; RECOGNITION; SEMANTICS; TEMPORAL LOBE; THALAMUS; TREATMENT DURATION;

AGED; BLOOD GLUCOSE; BRAIN; CHROMIUM; COGNITION; DEMENTIA; DEPRESSION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEARNING; MALE; MEMORY; MEMORY DISORDERS; MENTAL RECALL; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PICOLINIC ACIDS; RECOGNITION (PSYCHOLOGY); RETENTION (PSYCHOLOGY);

EID: 77952208369     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683010X12611460764084     Document Type: Article

References (55)

1. Frolich L, Blum-Degen D, Berstein HG et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 1998; 105: 423-438.
2. Watson GS, Craft S. The role of insulin resistance in the pathogenesis of Alzheimer's disease. CNS Drugs 2003; 17: 27-45.
3. Baura GD, Foster DM, Kaiyala K et al. Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 1996; 45: 86-90.
4. Wallum BJ, Taborsky GJ, Porte D et al. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endo Metab 1987; 64: 190-194.
5. Baker LD, Cholerton B, Reger M et al. Hyperinsulinemia predicts cognitive performance for normal older adults and for patients with Alzheimer's disease. Neurobiol Aging 2004; 25 (Suppl 2): 110.
6. Craft S. Insulin resistance syndrome and Alzheimer's disease: ageand obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 2005; 26 (Suppl): S65-S69.
7. RegerM,Watson GS, Cholerton B et al. Cortisol infusion attenuates insulin's facilitation of verbal memory in patients with Alzheimer's disease. Neurobiol Aging 2004; 25: 168.
8. Watson GS, Cholerton BA, Reger MA et al. Preserved cognition in patients with early Alzheimer's disease and amnestic mild cognitive impairment during treatment with rosiglitazone. Am J Geriatr Psychiatry 2005; 13: 950-958.
9. Vincent J. The biochemistry of chromium. J Nutr 2000; 130: 715-718.
10. Cefalu WT, Bell-Farrow AD, Stegner J et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Element Exp Med 1999; 12: 71-83.
11. Juturu V, Komorowski JR, Devine JP et al. Absorption and excretion of chromium from orally administered chromium chloride, chromium acetate and chromium oxide in rats. Trace Element Electrolyte 2003; 20: 23-28.
12. Anderson RA, Cheng N, Bryden NA et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997; 46: 1786-1791.
13. Morris BW, Kouta S, Robinson R et al. Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus. Diabet Med 2000; 17: 684-686.
14. Rabinovitz H, Leibovitz A, Madar Z et al. Blood glucose and lipid levels following chromium supplementation in diabetic elderly patients on a rehabilitation program. Gerontologist 2000; 40 (Suppl): 38.
15. Wilson BE, Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res 1995; 23: 179-184.
16. National Research Council. Recommended Dietary Allowances, 10th edn. Washington DC: National Academy Press, 1989.
17. Rajpathak S, Rimm EB, Li T et al. Levels of chromium in toenails and the risk of cardiovascular disease in diabetic men. Circulation 2004; 109: 34.
18. Institute of Medicine Food and Nutrition Board. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press, 2001.
19. Komorowski JR, Greenberg D, Juturu V. Chromium picolinate does not produce chromosome damage. Toxicol in Vitro 2008; 22: 819-826.
20. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 1-12.
21. Chertkow H, Nasreddine Z, Joanette Y. Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis. Alzheimer's Dement 2007; 3: 266-282. (Pubitemid 47553568)
22. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009; 119: 252-265.
23. Crook T, Bartus RT, Ferris SH et al. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change. Dev Neuropsychol 1986; 2: 261-276.
24. Neilsen H, Lolk A, Kragh-Sorensen P. Age-associated memory impairment - pathological memory decline or normal aging? Scand J Psychol 1998; 39: 33-37.
25. Goldman WP, Morris JC. Evidence that age-associated memory impairment is not a normal variant of aging. Alzheimer Dis Assoc Disord 2001; 15: 72-79.
26. Saykin AJ, Wishart HA, Rabin LA et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 2006; 76: 834-842.
27. Skoog I, Gustafson D. Hypertension, hypertension-clustering factors and Alzheimer's disease. Neurol Res 2003; 25: 675-680.
28. Alzheimer's Association. 2008 Alzheimer's disease facts and figures. Alzheimer's Dement 2008; 4: 110-133.
29. Shah T, Tangalos EG, Petersen RC. Mild cognitive impairment: when is it a precursor to Alzheimer's disease. Geriatrics 2000; 55: 62-68.
30. Krikorian R, Zimmerman ME, Fleck DE. Inhibitory control in obsessive-compulsive disorder. Brain Cogn 2004; 54: 257-259.
31. Hughes CP, Berg L, Danziger WL et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
32. Lynch CA, Walsh C, Blanco A et al. The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disorder 2006; 21: 40-43.
33. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2192.
34. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
35. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.
36. Delis D, Kramer J, Kaplan E et al. California Verbal Learning Test manual. San Antonio, TX: The Psychological Corporation, 1987.
37. Robert C, Borella E, Fagot D, Lecerf T, de Ribaupiere A. Working memory and inhibitory control across the life span: intrusion errors in the Reading Span Test. Mem Cogn 2009; 37: 336-345.
38. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression rating scale: a preliminary report. J Psychiatr Res 1983; 17: 37-49.
39. Brink TL, Yesavage JA, Lum O et al. Screening tests for geriatric depression. Clin Gerontol 1982; 1: 37-43.
40. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr 1991; 3: 23-28.
41. Sheeber LB, Sorensen ED, Howe SR. Data analytic techniques for treatment outcome studies with pretest/posttest measurements: an extensive primer. J Psychiatr Res 1996; 30: 185-199.
42. Cohen S. Statistical power analysis. New York: Lawrence Erlbaum Associates, 1988.
43. Lee J-H, Garwood M, Menon R et al. High contrast and fast threedimensional magnetic resonance imaging at high fields. Magn Reson Med 1995; 34: 308-312.
44. Ogawa S, Tank DW, Menon R et al. Intensive signal changes accompanying sensory stimulation: Functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci USA 1992; 89: 5951-5955.
45. Kwong KK, Belliveau JW, Chesler DA et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 1992; 89: 5675.
46. Schmithorst VJ, Dardzinski BJ, Holland SK. Simultaneous correction of ghost and geometric distortion artifacts in EPI using a multiecho reference scan. IEEE Trans Med Imaging 2001; 20: 535-539.
47. Callicott JH, Ramsey NF, Tallent K et al. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 1998; 18: 186-196.
48. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996; 29: 162-173.
49. Park DC, Reuter-Lorenz P. The adaptive brain: aging and neurocognitive scaffolding. Annu Rev Psychol 2009; 60: 173-196.
50. Delis DC, Weter SR, Jocobson MW et al. Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia. J Int Neuropsychol Soc 2005; 11: 708-715.
51. Baldo JV, Delis D, Kramer J, Schmamura AP. Memory performance on the California Verbal Learning Test-II: Findings from patients with focal frontal lesions. J Int Neuropsychol Soc 2002; 8: 539-546.
52. Wegesin DJ, Jacobs DM, Zubin NR et al. Source memory and encoding strategy in normal aging. J Clin Exp Neuropsychol 2000; 22: 455-464.
53. Savage CR, Deckersbach T, Heckers S et al. Prefrontal systems underlying spontaneous and directed strategic processing during verbal learning. Brain Cogn 2001; 47: 116-120. (Pubitemid 33732040)
54. Jonides J, Lacy SC, Nee DE. Processes of working memory in mind and brain. Cur Dir Psychol Sci 2005; 14: 2-5.
55. Owen AM,McMillan KM, Laird AR et al. N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies. Hum Brain Map 2005; 25: 46-59.